Januvia Tablet, Film Coated
Product Images NDC 50090-4086

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Januvia (NDC 50090-4086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Sitagliptin Chemical Structure (Januvia 01)

Image Of Sitagliptin Chemical Structure (Januvia 01)
Chemical structure of sitagliptin phosphate monohydrate, the active ingredient in JANUVIA 50 mg oral tablets, showing its molecular framework including trifluoromethyl group and ring structures as labeled.*
FDA Label Image

Image Of Figure 1 (Januvia 02)

Image Of Figure 1 (Januvia 02)
This line graph shows the least squares mean change from baseline over 24 weeks for different treatments including placebo, sitagliptin 100 mg once daily, metformin 500 mg twice daily, metformin 1000 mg twice daily, and combined doses of sitagliptin 50 mg twice daily with metformin 500 mg or 1000 mg twice daily. The x-axis represents weeks, and the y-axis represents the mean change from baseline.*
FDA Label Image

Image Of Figure 2 (Januvia 03)

Image Of Figure 2 (Januvia 03)
A line graph showing the LS mean change from baseline over 52 weeks, comparing Januvia 100 mg (black diamonds) and Glipizide (open circles). The x-axis represents the week number, and the y-axis shows the LS mean change from baseline, with both treatments showing a decrease that plateaus and then slightly increases near the end of the study period.*
FDA Label Image

Label Image (Lbl500904086)

Label Image (Lbl500904086)
Packaging label for JANUVIA 50 mg film-coated tablets by A-S Medication Solutions. The label states each tablet contains 50 mg sitagliptin phosphate, equivalent to 50 mg sitagliptin. The container holds 90 tablets with storage instructions between 68 to 77 degrees Fahrenheit. Product NDC is 50090-4086-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.